Constance, Germany

Volker Gekeler

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 7.8

ph-index = 2

Forward Citations = 21(Granted Patents)


Location History:

  • Constance, DE (2010 - 2016)
  • Konstanz, DE (2015 - 2018)

Company Filing History:


Years Active: 2010-2018

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Volker Gekeler: Innovator in Anticancer Agents

Introduction

Volker Gekeler, an esteemed inventor based in Constance, Germany, has made significant contributions to the field of medicinal chemistry. With a remarkable portfolio of 12 patents, Gekeler's work primarily focuses on the development of innovative compounds that have the potential to revolutionize treatment protocols in oncology.

Latest Patents

Among his most recent inventions are a series of substituted imidazoquinolines, detailed in his latest patents. These compounds, characterized by their substituted amine or amide functionality at the 1-position, have been shown to act as effective Toll-like Receptor 7 activators. The implications of this work are profound, as these innovative compounds are being researched for their efficacy as anticancer agents, offering hope for new therapeutic avenues in cancer treatment.

Career Highlights

Gekeler’s impressive career has seen him affiliated with notable companies such as 4SC AG and Bayer Intellectual Property GmbH. His expertise has not only propelled his career forward but has also fostered advancements in drug discovery and development.

Collaborations

Throughout his career, Volker Gekeler has teamed up with various talented professionals, including Astrid Zimmermann and Thomas Maier. These collaborations have played a crucial role in driving innovation and expanding the understanding of pharmaceutical sciences.

Conclusion

In conclusion, Volker Gekeler’s contributions to the field of medicinal chemistry through his inventions and collaborations are instrumental in advancing the development of effective cancer treatments. With 12 patents to his name, his work continues to inspire the research community and push the boundaries of what is possible in therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…